Background: Systolic heart failure (HF) is frequently accompanied by diastolic dysfunction and sleep-disordered breathing (SDB). Objectives: The objective of this subset analysis was to determine effect sizes of auto-servo ventilation (ASV and biphasic positive airway pressure ASV) on echocardiographic measures of diastolic function in patients with systolic HF and SDB. Methods: Thirty-two patients with stable systolic HF, concomitant diastolic dysfunction [age 66 ± 9 years old, left ventricular (LV) ejection fraction: 30 ± 7% and New York Heart Association class II: 72%] and SDB (apnea-hypopnea index, AHI: 48 ± 19/h; 53% had predominantly obstructive sleep apnea) receiving either ASV (n = 19) or optimal medical treatment (control, n = 13) were analyzed in a randomized controlled clinical trial. Polysomnographic and echocardiographic measurements were obtained at baseline and after 12 weeks. Results: AHI significantly improved in the ASV group compared to the control group (-39 ± 18 vs. -0.2 ± 13.2/h, p < 0.001). At baseline, 24 (75%) patients had impaired LV relaxation, and 8 (25%) had a pseudo-normalized filling pattern. At the 12-week control visit, diastolic function assessed by the isovolumetric relaxation time (-10.3 ± 26.1 vs. 9.3 ± 49.1, p = 0.48) and deceleration time (-43.9 ± 88.8 vs. 12.4 ± 68.8, p = 0.40) tended to improve after ASV treatment, but did not reach statistical significance. Likewise, the proportion of patients whose diastolic dysfunction improved was nonsignificantly higher in the ASV than in the control group, respectively (37 vs. 15%, p = 0.25). Conclusions: ASV treatment efficiently abolishes SDB in patients with stable systolic HF and concomitant diastolic dysfunction, and was associated with a statistically nonsignificant improvement in measures of diastolic dysfunction. Thus, these data provide estimates of effect size and justify the evaluation of the effects of ASV on diastolic function in larger randomized controlled trials.

1.
Mosterd A, Hoes AW: Clinical epidemiology of heart failure. Heart 2007;93:1137-1146.
2.
Giannuzzi P, Temporelli PL, Bosimini E, Silva P, Imparato A, Corrà U, et al: Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. J Am Coll Cardiol 1996;28:383-390.
3.
Hansen A, Haass M, Zugck C, Krueger C, Unnebrink K, Zimmermann R, et al: Prognostic value of Doppler echocardiographic mitral inflow patterns: implications for risk stratification in patients with chronic congestive heart failure. J Am Coll Cardiol 2001;37:1049-1055.
4.
Pinamonti B, Di Lenarda A, Sinagra G, Camerini F: Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and hemodynamic correlations and prognostic implications. Heart Muscle Disease Study Group. J Am Coll Cardiol 1993;22:808-815.
5.
Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, et al: Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 1998;97:2154-2159.
6.
Lanfranchi PA, Braghiroli A, Bosimini E, Mazzuero G, Colombo R, Donner CF, et al: Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 1999;99:1435-1440.
7.
Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Töpfer V: Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 2007;9:251-257.
8.
Solin P, Bergin P, Richardson M, Kaye DM, Walters EH, Naughton MT: Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 1999;99:1574-1579.
9.
Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE, et al: Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107:68-73.
10.
Shivalkar B, van de Heyning C, Kerremans M, Rinkevich D, Verbraecken J, de Backer W, et al: Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol 2006;47:1433-1439.
11.
Jaffe LM, Kjekshus J, Gottlieb SS: Importance and management of chronic sleep apnoea in cardiology. Eur Heart J 2013;34:809-815.
12.
Jilek C, Krenn M, Sebah D, Obermeier R, Braune A, Kehl V, et al: Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study. Eur J Heart Fail 2011;13:68-75.
13.
Buchner S, Greimel T, Hetzenecker A, Luchner A, Hamer OW, Debl K, et al: Natural course of sleep-disordered breathing after acute myocardial infarction. Eur Respir J 2012;40:1173-1179.
14.
Bitter T, Westerheide N, Prinz C, Hossain MS, Vogt J, Langer C, et al: Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. Eur Heart J 2011;32:61-74.
15.
Brutsaert DL: Cardiac failure: quo vadis? Eur J Heart Fail 2010;12:785-788.
16.
Kasai T, Usui Y, Yoshioka T, Yanagisawa N, Takata Y, Narui K, et al: Effect of flow-triggered adaptive servo-ventilation compared with continuous positive airway pressure in patients with chronic heart failure with coexisting obstructive sleep apnea and Cheyne-Stokes respiration. Circ Heart Fail 2010;3:140-148.
17.
Fietze I, Blau A, Glos M, Theres H, Baumann G, Penzel T: Bi-level positive pressure ventilation and adaptive servo ventilation in patients with heart failure and Cheyne-Stokes respiration. Sleep Med 2008;9:652-659.
18.
Pepperell JCT, Maskell NA, Jones DR, Langford-Wiley BA, Crosthwaite N, Stradling JR, et al: A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med 2003;168:1109-1114.
19.
Arias MA, García-Río F, Alonso-Fernández A, Mediano O, Martínez I, Villamor J: Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 2005;112:375-383.
20.
Bitter T, Westerheide N, Faber L, Hering D, Prinz C, Langer C, et al: Adaptive servoventilation in diastolic heart failure and Cheyne-Stokes respiration. Eur Respir J 2010;36:385-392.
21.
Arzt M, Series F, Lewis K, Escourrou P, Obermeier R, Kehl V, et al: Effects of auto-servo ventilation on cardiovascular function in patients with congestive heart failure and sleep-disordered breathing - a multicenter randomised controlled trial. Eur Respir J 2011;38(suppl 55):P1743.
22.
Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikowski P, Poole-Wilson PA, et al: ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
23.
Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al: Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-1463.
24.
Devereux RB, Koren MJ, de Simone G, Okin PM, Kligfield P: Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease. Eur Heart J 1993;14:8-15.
25.
Voelker W: Strukturierter Datensatz zur Befunddokumentation in der Echokardiographie - Version 2004 für den Arbeitskreis ‘Standardisierung und LV-Funktion' der Arbeitsgruppe Kardiovaskulärer Ultraschall der DGK. Z Kardiol 2004;93:987-1004.
26.
Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT, et al: Systolic and diastolic heart failure in the community. JAMA 2006;296:2209-2216.
27.
Baguet J, Barone-Rochette G, Lévy P, Vautrin E, Pierre H, Ormezzano O, et al: Left ventricular diastolic dysfunction is linked to severity of obstructive sleep apnoea. Eur Respir J 2010;36:1323-1329.
28.
Wachter R, Lüthje L, Klemmstein D, Lüers C, Stahrenberg R, Edelmann F, et al: Impact of obstructive sleep apnoea on diastolic function. Eur Respir J 2013;41:376-383.
29.
Somers VK, Dyken ME, Clary MP, Abboud FM: Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995;96:1897-1904.
30.
Dincer HE, O'Neill W: Deleterious effects of sleep-disordered breathing on the heart and vascular system. Respiration 2006;73:124-130.
31.
Brack T, Randerath W, Bloch KE: Cheyne-Stokes respiration in patients with heart failure: prevalence, causes, consequences and treatments. Respiration 2012;83:165-176.
32.
Bradley TD, Hall MJ, Ando S, Floras JS: Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure. Chest 2001;119:1827-1835.
33.
Sharma BK, Bakker JP, McSharry DG, Desai AS, Javaheri S, Malhotra A: Adaptive servoventilation for treatment of sleep-disordered breathing in heart failure: a systematic review and meta-analysis. Chest 2012;142:1211-1221.
34.
Töpfer V, El-Sebai M, Wessendorf TE, Moraidis I, Teschler H: Adaptive Servoventilation bei chronischer Herzinsuffizienz: Wirkung auf Cheyne-Stokes-Atmung und Lebensqualität. Pneumologie 2004;58:28-32.
35.
Randerath WJ, Galetke W, Kenter M, Richter K, Schäfer T: Combined adaptive servo-ventilation and automatic positive airway pressure (anticyclic modulated ventilation) in co-existing obstructive and central sleep apnea syndrome and periodic breathing. Sleep Med 2009;10:898-903.
36.
Philippe C, Stoïca-Herman M, Drouot X, Raffestin B, Escourrou P, Hittinger L, et al: Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart 2006;92:337-342.
37.
Arzt M, Wensel R, Montalvan S, Schichtl T, Schroll S, Budweiser S, et al: Effects of dynamic bilevel positive airway pressure support on central sleep apnea in men with heart failure. Chest 2008;134:61-66.
38.
Hastings PC, Vazir A, Meadows GE, Dayer M, Poole-Wilson PA, McIntyre HF, et al: Adaptive servo-ventilation in heart failure patients with sleep apnea: a real world study. Int J Cardiol 2010;139:17-24.
39.
Randerath WJ, Nothofer G, Priegnitz C, Anduleit N, Treml M, Kehl V, et al: Long-term auto-servoventilation or constant positive pressure in heart failure and co-existing central with obstructive sleep apnea. Chest 2012;142:440-447.
40.
Bradley TD, Logan AG, Kimoff RJ, Sériès F, Morrison D, Ferguson K, et al: Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005;353:2025-2033.
41.
Koyama T, Watanabe H, Terada S, Makabe S, Igarashi G, Nobori K, et al: Adaptive servo-ventilation improves renal function in patients with heart failure. Respir Med 2011;105:1946-1953.
42.
Oldenburg O, Bitter T, Lehmann R, Korte S, Dimitriadis Z, Faber L, et al: Adaptive servoventilation improves cardiac function and respiratory stability. Clin Res Cardiol 2011;100:107-115.
43.
Steiner S, Schannwell CM, Strauer BE: Left ventricular response to continuous positive airway pressure: role of left ventricular geometry. Respiration 2008;76:393-397.
44.
Johnson CB, Beanlands RS, Yoshinaga K, Haddad H, Leech J, de Kemp R, et al: Acute and chronic effects of continuous positive airway pressure therapy on left ventricular systolic and diastolic function in patients with obstructive sleep apnea and congestive heart failure. Can J Cardiol 2008;24:697-704.
45.
Yoshinaga K, Burwash IG, Leech JA, Haddad H, Johnson CB, de Kemp RA, et al: The effects of continuous positive airway pressure on myocardial energetics in patients with heart failure and obstructive sleep apnea. J Am Coll Cardiol 2007;49:450-458.
46.
Dursunoglu D, Dursunoglu N, Evrengül H, Ozkurt S, Kuru O, Kiliç M, et al: Impact of obstructive sleep apnoea on left ventricular mass and global function. Eur Respir J 2005;26:283-288.
47.
Damy T, Paulino A, Margarit L, Drouot X, Stoica M, Vermes E, et al: Left ventricle remodelling is associated with sleep-disordered breathing in non-ischaemic cardiopathy with systolic dysfunction. J Sleep Res 2011;20:101-109.
48.
Colish J, Walker JR, Elmayergi N, Almutairi S, Alharbi F, Lytwyn M, et al: Obstructive sleep apnea: effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI. Chest 2012;141:674-681.
49.
Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, et al: Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003;348:1233-1241.
50.
Arzt M, Schroll S, Series F, Lewis K, Benjamin A, Escourrou P, et al: Auto-servo ventilation in heart failure with sleep apnea - a randomized controlled trial. Eur Respir J 2012, E-pub ahead of print.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.